​

Funding Round

Series B - Ascus Biosciences

Series B - Ascus Biosciences

Investment Firm

Overview

Ascus Biosciences uses novel microbial community screening methods to discover, develop, and commercialize next generation feed additives.

Announced Date

May 27, 2020

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Temasek Holdings

Temasek Holdings

Temasek Holdings is a early_stage_venture and late_stage_venture and private_equity and secondary_market firm.

Participant Investors

3

Investor Name
Participant InvestorAnterra Capital
Participant InvestorFormation 8
Participant InvestorTemasek Holdings

Round Details and Background

Ascus Biosciences raised $46000000 on 2020-05-27 in Series B

Ascus Biosciences uses novel microbial community screening methods to discover, develop, and commercialize next generation feed additives.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 31, 2019
Debt Financing - Ascus Biosciences
-5.0M
May 27, 2020
Series B - Ascus Biosciences
4-46.0M

Recent Activity

There is no recent news or activity for this profile.